Three-Dimensional Fluoroscopic Guidance During Transbronchial Cryobiopsy

Status Completed

Clinical Trial Summary

This study assesses the effectiveness of transbronchial cryobiopsy guided by 3-dimensional fluoroscopy. Transbronchial cryobiopsy is a procedure to collect lung tissue. The main side effect seen after a transbronchial cryobiopsy is pneumothorax (air leaking out of the lung, which may cause a completely or partially collapsed lung). The standard imaging scans used during this procedure are 2-dimensional (like a photo), which can make it difficult for the doctor to know exactly where the biopsy tool is during the procedure. If the exact location of the device is not clear, a patient can be at a higher risk of pneumothorax. Using a 3-dimensional imaging technique may help to decrease the risk of pneumothorax during transbronchial cryobiopsy.

Clinical Trial Description

PRIMARY OBJECTIVE: I. To determine if transbronchial cryobiopsy guided by three-dimensional fluoroscopy reduces the incidence of pneumothorax up to 72 hours after transbronchial cryobiopsy. SECONDARY OBJECTIVE: I. To describe outcomes of cryobiopsy, need for interventions related to transbronchial cryobiopsy, radiation dose, and any complications or adverse events after transbronchial cryobiopsy guided by three-dimensional fluoroscopy. OUTLINE: Patients undergo transbronchial cryobiopsy guided by three-dimensional fluoroscopy. Patients' medical records are also reviewed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05059691
Study type	Observational
Source	M.D. Anderson Cancer Center
Contact
Status	Completed
Phase
Start date	March 30, 2021
Completion date	May 11, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04931017` - Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer	Phase 2
Recruiting	`NCT05898594` - Lung Cancer Screening in High-risk Black Women	N/A
Not yet recruiting	`NCT06038526` - Evaluation of Canakinumab in High-Risk Former-Smokers	Phase 2
Terminated	`NCT02856581` - Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes	Phase 3
Completed	`NCT04922697` - Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study	N/A
Recruiting	`NCT04644952` - The Rise in Robotic Atypical Segmentectomies
Completed	`NCT01896778` - Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer	N/A
Recruiting	`NCT05407168` - Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool	N/A
Completed	`NCT04267874` - Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study	Early Phase 1
Recruiting	`NCT02408861` - Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery	Phase 1
Recruiting	`NCT03709953` - Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma	Phase 2
Active, not recruiting	`NCT03267524` - Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers	N/A
Recruiting	`NCT04147494` - Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues	Early Phase 1
Completed	`NCT02237183` - Iloprost in Preventing Lung Cancer in Former Smokers	Phase 1
Recruiting	`NCT04783168` - Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study	N/A
Completed	`NCT04635761` - Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening	N/A
Recruiting	`NCT06445192` - Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial	N/A
Active, not recruiting	`NCT03164486` - First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide	Early Phase 1
Recruiting	`NCT05802186` - Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study	N/A
Active, not recruiting	`NCT01696968` - Screening for Lung Cancer in Older Patients (PLCO Screening Trial)	N/A